Cartesian Therapeutics, Inc. (RNAC) Financials
RNAC Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 318.6 million | 443.9 million |
| March 31, 2026 | 288.4 million | 436.5 million |
| Dec. 31, 2025 | 296.4 million | 422.7 million |
| Sept. 30, 2025 | 372.7 million | 408.5 million |
RNAC Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -20.9 million | 2.1 million |
| March 31, 2026 | -22.2 million | 2.4 million |
| Dec. 31, 2025 | -18.2 million | 2.1 million |
| Sept. 30, 2025 | -16.9 million | 2.6 million |
RNAC Net Income
No data available :(
RNAC Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 147.6 million | 52.9 million | 11.0 million |
| March 31, 2026 | 118.6 million | - | 7.7 million |
| Dec. 31, 2025 | 125.1 million | - | 8.5 million |
| Sept. 30, 2025 | 143.4 million | - | 12.6 million |
RNAC Shares Outstanding
RNAC Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 272000 | 20.4 million | 8.7 million | - |
| March 31, 2026 | 27000 | 19.5 million | 7.1 million | - |
| Dec. 31, 2025 | 492000 | 14.7 million | 8.2 million | - |
| Sept. 30, 2025 | 1.3 million | 13.8 million | 7.7 million | 1.1 million |
RNAC Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | - | - |
| March 31, 2026 | 78000 | - |
| Dec. 31, 2025 | 947000 | - |
| Sept. 30, 2025 | 452000 | 12.8 million |
RNAC Revenue by Segment
Graph available only for paid members. Upgrade to see it.
RNAC
Price: $10.37
52 week price:
Earnings Per Share: -5.72 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 265.0 million